New Initiative Aims to Boost Workplace Coverage of Obesity Medications
A leading pharmaceutical company has unveiled a new initiative aimed at helping businesses include obesity treatments in their healthcare coverage. This move is intended to overcome a significant obstacle to patient access, as high costs often prevent many companies from covering these medications.
The company and its main competitor have previously reduced the prices of their popular obesity injections for those willing to pay completely out-of-pocket. However, due to the high cost of these treatments, coverage is inconsistent amongst employers, leaving about half of those with private insurance unable to begin or continue treatment.
Challenges with Current Coverage
Obesity and diabetes treatments can cost over $1,000 a month, a prohibitive expense for many individuals and businesses. A recent survey indicated that only about a fifth of businesses with over 200 employees, and 43% of those with over 5,000 employees, cover these types of medications for weight loss.
Company representatives hope that this new initiative may encourage more employers to include obesity treatments in their coverage plans.
Introducing the "Employer Connect" Platform
The pharmaceutical company's new "Employer Connect" platform provides businesses with greater flexibility in covering obesity treatments. The aim is to widen employee access to these medications at lower out-of-pocket costs, while also keeping expenses manageable for companies.
The platform addresses key concerns for employers when considering obesity medication coverage, such as clarity around drug prices, flexibility in benefits design, and the option to select from various independent administrators.
Through this program, businesses can pay a reduced price of $449 per month for a new multi-dose form of a popular obesity treatment. This arrangement doesn't involve rebates, offering employers a clearer picture of the actual cost and helping them decide whether they can afford to offer the medication.
A New Approach to Benefit Design
Instead of adhering to traditional benefit designs, employers can use the platform to link with a variety of third-party program administrators that assist in managing obesity treatment benefits and costs. This approach recognizes that every employer is unique and may need to tailor their coverage to their specific needs and workforce.
Employers can select from over 15 administrators to create benefits that meet their budget and employees' needs. Some administrators may handle the logistics of obesity benefits for employees, dealing with areas like enrollment, eligibility, and claims. Others may offer comprehensive obesity management, including telehealth, nutrition, and lifestyle support for patients.
The company plans to increase the number of program administrators on the platform. All administrators will offer the same medication at the same price, allowing employers to select the best service that meets their specific program needs.
Aiming for Competitive Services
The goal of the "Employer Connect" platform is to foster competition among administrators, offering employers the best value for their services. This initiative marks a significant step towards making obesity treatments more accessible to employees while keeping costs manageable for businesses.